Kepler Capital analyst Christian Faitz maintained a Buy rating on Clariant AG (SIX:CLN) on Wednesday, setting a price target of CHF24, which is approximately 21.85% above the present share price of $21.26.
Faitz expects Clariant AG to post earnings per share (EPS) of $0.00 for the fourth quarter of 2021.
The current consensus among 8 TipRanks analysts is for a Hold rating of shares in Clariant AG, with an average price target of $22.37.
The analysts price targets range from a high of $25.91 to a low of $19.65.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $0 and a net profit of $0. The company's market cap is $6.42 billion.
According to TipRanks.com, Kepler Capital analyst Christian Faitz is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 17.3% and a 67.93% success rate.
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals. It operates through the following segments: Care Chemicals; Catalysis; Natural Resources;Plastics and Coatings; and Corporate. The Care Chemicals segment comprises the industrial and consumer specialties business unit (BU), food additives as well as the industrial biotechnology business. The Catalysis segment develops, manufactures, and sells a catalyst product for the chemical, fuel, and automotive industries. The Natural Resources segment comprises BUs oil and mining services and functional minerals. The Plastics and Coatings segment includes the BUs additives, pigments, and masterbatches. The company was founded in 1995 and is headquartered in Muttenz, Switzerland.